Tech Philanthropists Expand Biomedical Funding as OpenAI, Anthropic IPOs Loom

The Facts

  • OpenAI and Anthropic, both based in San Francisco, plan to go public in the next year or so, in IPOs expected to make many employees wealthy. Nature only
  • Altos Labs, a longevity-focused company in Redwood City, California, launched in 2022 with $3 billion from backers including Yuri Milner and Jeff Bezos. Nature only
  • The Chan Zuckerberg Initiative has spent about $4 billion on basic scientific research and other causes and plans to spend up to $10 billion more over the next decade. In April it announced $500 million for predictive AI models of human cells. Nature only
  • The OpenAI Foundation pledged last year to spend $25 billion on health, disease cures and AI resilience. It has announced more than $100 million for Alzheimer's research and $125 million for life-sciences data projects this year. Nature only
  • In 2024, non-profits including philanthropies supported an estimated $25 billion in US research and development, about 11% of total US research funding, according to the Science Philanthropy Alliance. Nature only
Dive deeper · 3 more factsShow less
  • In 2015 Mark Zuckerberg and Priscilla Chan pledged 99% of their Facebook shares, then valued at $45 billion, to the Chan Zuckerberg Initiative. By 2025 Bill and Melinda French Gates had donated nearly $64 billion to the Gates Foundation. Nature only
  • Science philanthropy is also growing outside the US, including Tencent-funded Xplorer Prize in China, the Xiaomi Foundation in Beijing, and the Serrapilheira Institute in Brazil, founded in 2017. Nature only
  • Private philanthropies lack the public reporting requirements of government funders, and project results are not necessarily published. Nature only

Context

Nature published a news feature and an editorial on the growing role of technology-wealth philanthropy in biomedical research. Both note that planned IPOs by OpenAI and Anthropic could create new wealth that may flow into science funding.

The pieces describe donors favoring high-risk, long-term and AI-driven research, and raise accountability concerns, including limited transparency. The editorial states Nature's view that such funders should be more transparent. Both articles are from the same outlet, so corroboration reflects agreement between its two pieces, not independent outlets.

Conflicting Reports

  • IPO valuations differ: the news feature says some analysts project Anthropic could raise $2 trillion and OpenAI is reportedly targeting $1.4 trillion (with OpenAI delaying to 2027), while the editorial says both could be valued at more than $1 trillion apiece.

How the Agent Panel Scored This

Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 1.

3 Informed Citizen The story is a feature and editorial about trends in tech-wealth philanthropy and possible future IPO wealth, reporting no new concrete funding action of major scale beyond previously announced pledges, so its impact on ordinary people is limited.
3 Science & Tech Analyst This is a feature and editorial about trends in tech-wealth philanthropy, reporting no new concrete funding event beyond previously announced pledges and speculative future IPOs, so its impact is limited.
3 News Editor This is a feature and editorial about trends in tech-wealth philanthropy, with concrete facts being mostly prior pledges and past spending rather than a new major event, so its impact is limited to a niche science-funding audience.
3 Critical Reader The story is a feature and editorial about trends in tech-wealth philanthropy, summarizing prior pledges and existing spending with no new concrete funding action or verified measurable change, and the IPOs are only prospective.
3 Business Analyst This is a feature and editorial on tech-wealth philanthropy describing existing funding commitments and speculative future IPO wealth, with no new concrete market-moving action, so it is minor news with limited economic impact.
3 Global Affairs Analyst This is a feature and editorial on philanthropy trends, reporting prior commitments and speculative future IPO wealth rather than a new concrete event, so it is minor news with limited immediate impact.
2 Policy Expert The story is a feature and editorial on philanthropy trends, reporting prior pledges and speculative future IPO wealth without any new concrete governmental action, enacted policy, or court ruling.

Sources (2)